Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy.

× No keyword cloud information.

9 in total

1. Extensive cutaneous moniliasis. Treatment with amphotericin B.

Authors: D BUZDYGAN; M LEPPER; I NEUHAUSER; I M ROSENTHAL
Journal: Am J Dis Child Date: 1961-08

2. Chronic mucocutaneous candidiasis, deficiency of delayed hypersensitivity, and selective local antibody defect.

Authors: R A Chilgren; P G Quie; H J Meuwissen; R Hong
Journal: Lancet Date: 1967-09-30 Impact factor: 79.321

3. Infection and nitroblue-tetrazolium reduction by neutrophils. A diagnostic acid.

Authors: B H Park; S M Fikrig; E M Smithwick
Journal: Lancet Date: 1968-09-07 Impact factor: 79.321

4. Immunological observations in chronic mucocutaneous candidiasis.

Authors: L Canales; R O Middlemas; J M Louro; M A South
Journal: Lancet Date: 1969-09-13 Impact factor: 79.321

5. Spontaneous in vitro reduction of nitroblue tetrazolium by neutrophils of adult patients with bacterial infection.

Authors: G Matula; P Y Paterson
Journal: N Engl J Med Date: 1971-08-05 Impact factor: 91.245

Review 6. Transfer factor.

Authors: H S Lawrence
Journal: Adv Immunol Date: 1969 Impact factor: 3.543

7. The susceptibility to moniliasis in children with endocrine hypofunction.

Authors: D B Louria; D Shannon; G Johnson; L Caroline; A Okas; C Taschdjian
Journal: Trans Assoc Am Physicians Date: 1967

8. One-way stimulation in mixed leukocyte cultures.

Authors: F H Bach; N K Voynow
Journal: Science Date: 1966-07-29 Impact factor: 47.728

9. Studies of PPLO infection. V. Inhibition of lymphocyte mitosis and antibody formation by mycoplasmal extracts.

Authors: M S Simberkoff; G J Thorbecke; L Thomas
Journal: J Exp Med Date: 1969-06-01 Impact factor: 14.307

9 in total

28 in total

1. Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI.

Authors: J E Domer; R E Garner; R N Befidi-Mengue
Journal: Infect Immun Date: 1989-03 Impact factor: 3.441

2. Characterization of the cellular immune function of patients with chronic mucocutaneous candidiasis.

Authors: D de Moraes-Vasconcelos; N M Orii; C C Romano; R Y Iqueoka; A J Duarte
Journal: Clin Exp Immunol Date: 2001-02 Impact factor: 4.330

3. Precipitins to Candida albicans in chronic mucocutaneous candidiasis studied by crossed immunoelectrophoresis with intermediate gel. Correlation with clinical and immunological findings.

Authors: N H Axelsen; C H Kirkpatrick; R H Buckley
Journal: Clin Exp Immunol Date: 1974-07 Impact factor: 4.330

10. Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis.

Authors: A Fischer; J J Ballet; C Griscelli
Journal: J Clin Invest Date: 1978-11 Impact factor: 14.808

Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy.

1. Extensive cutaneous moniliasis. Treatment with amphotericin B.

2. Chronic mucocutaneous candidiasis, deficiency of delayed hypersensitivity, and selective local antibody defect.

3. Infection and nitroblue-tetrazolium reduction by neutrophils. A diagnostic acid.

4. Immunological observations in chronic mucocutaneous candidiasis.

5. Spontaneous in vitro reduction of nitroblue tetrazolium by neutrophils of adult patients with bacterial infection.

Review 6. Transfer factor.

7. The susceptibility to moniliasis in children with endocrine hypofunction.

8. One-way stimulation in mixed leukocyte cultures.

9. Studies of PPLO infection. V. Inhibition of lymphocyte mitosis and antibody formation by mycoplasmal extracts.

1. Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI.

2. Characterization of the cellular immune function of patients with chronic mucocutaneous candidiasis.

3. Precipitins to Candida albicans in chronic mucocutaneous candidiasis studied by crossed immunoelectrophoresis with intermediate gel. Correlation with clinical and immunological findings.

4. Immune responses to yeast and mycelial forms of Candida albicans in intraperitoneally infected mice.

Review 5. Chronic mucocutaneous candidosis: a review.

6. Immunity to Candida albicans.

7. Immunoadjuvant activity of amphotericin B as displayed in mice infected with Candida albicans.

8. Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis.

9. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis.

10. Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis.